CLARKE MICHAEL F ET AL: "Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells", CANCER RESEARCH, AACR, US PHILADELPHIA, PA, vol. 66, no. 19, 1 October 2006 (2006-10-01), pages 9339-9344, XP002580692, ISSN: 1538-7445 (B1)

EP-A1- 2 111 869 (B1)

HOSEN N ET AL: "CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia", PNAS,, vol. 104, no. 26, 26 June 2007 (2007-06-26), pages 11008-11013, XP008109009, DOI: 10.1073/PNAS.0704271104 (B1)

JAISWAL SIDDHARTHA ET AL: "CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis", CELL, CELL PRESS, US, vol. 138, no. 2, 1 July 2009 (2009-07-01), pages 271-285, XP009160236, ISSN: 0092-8674, DOI: 10.1016/J.CELL.2009.05.046 (B1)

JAMIESON C ET AL: "Increased expression of CD47 is a constant marker in mouse and human myeloid leukemias", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 106, 1 January 2005 (2005-01-01), page 911A, XP008138745, ISSN: 0006-4971 (B1)

JOSÉ IGNACIO MARTIN-SUBERO ET AL: "Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia", CANCER GENETICS AND CYTOGENETICS., vol. 127, no. 2, 1 June 2001 (2001-06-01), pages 174-176, XP055405588, US ISSN: 0165-4608, DOI: 10.1016/S0165-4608(00)00431-3 (B1)

YOSHIKANE KIKUSHIGE ET AL: "TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells", CELL STEM CELL, CELL PRESS, US, vol. 7, no. 6, 6 October 2010 (2010-10-06) , pages 708-717, XP028184581, ISSN: 1934-5909, DOI: 10.1016/J.STEM.2010.11.014 [retrieved on 2010-11-17] (B1)

RAVINDRA MAJETI ET AL: "CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells", CELL, vol. 138, no. 2, 1 July 2009 (2009-07-01), pages 286-299, XP055277135, US ISSN: 0092-8674, DOI: 10.1016/j.cell.2009.05.045 (B1)

US-A1- 2004 213 792 (B1)

US-A1- 2007 287 163 (B1)

US-B1- 6 491 917 (B1)

US-B2- 6 733 743 (B1)

M. JAN ET AL: "Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 108, no. 12, 7 March 2011 (2011-03-07), pages 5009-5014, XP055029836, ISSN: 0027-8424, DOI: 10.1073/pnas.1100551108 (B1)